SwitzerlandSwitzerland

Switzerland

16.09.2003

Zürich - The new marketing initiative ‚Swiss Biotech' was formed earlier this year (www.swissbiotech.com). The goal of the initiative is to further the positioning of the Biotechnology sector of Switzerland nationally and internationally. It was started to spread the message of Switzerland as one of the top biotech locations in the world. This will be achieved by presenting a comprehensive picture of Swiss biotechnology including research, education, economics, finance and industry. Among the founding members are the established regional life science clusters, Basel, Zürich and the Geneva lake region.

SwitzerlandSwitzerland

21.10.2010

Bern - More than 25 experts from industry, academia and national funding agencies attended the workshop " Cleantech by Biotech - Exploiting the Value of Industrial Biotech in Chemistry and Materials Processing“ aimed at...

SwitzerlandSwitzerland

16.09.2010

Zurich – Pharmacists from the Swiss Federal Institute of Technology in Zurich have found a new way to treat chronic skin inflammation such as psoriasi (J. Exp. Med). In a mouse model for chronic cutanous inflammation, all...

SwitzerlandSwitzerland

15.09.2010

Basel – Swiss vaccine developer Okairos has completed Series B private financing round totalling EUR16 million. The company stated that funds will be used to advance the company’s pipeline of prophylactic and therapeutic vaccines...

SwitzerlandSwitzerland

13.09.2010

Zurich – Tecan has sold subsidiary Remp AG to US-specialist Nexus Biosystems Inc. for CHF12m (EUR9.4m). Remp was in charge of all of the activities involved in Tecan’s sample management business segment. In parallel with the...

SwitzerlandSwitzerland

03.09.2010

Geneva - Allosteric modulation specialist Addex Pharmaceuticals Ltd has observed efficacy of its oral pre-clincal drug candidate mGluR2 NAM in a model of Alzheimer's disease. The allosteric compound specifically inhibits...

SwitzerlandSwitzerland

20.08.2010

Lausanne – Cells present in the thymus can be reprogrammed to form skin stem cells without any need for genetic manipulation, according to a research group headed by Yann Barrandon (Ecole Polytechnique Fédérale Lausanne). When...

SwitzerlandSwitzerland

10.08.2010

The US Food and Drug Administration (FDA) is having to be vigilant on new fronts. The agency has given Novartis a ticking off for its behaviour on the world's largest social network, Facebook. The Swiss drugmaker apparently...

Displaying results 71 to 80 out of 276

< Previous 71-80 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-switzerland/browse/7/article/switzerland-27.html

Print Magazine

Event Video

All videos

Events

All Events

Stock list

All quotes

TOP

  • MOLOGEN7.65 EUR18.42%
  • BB BIOTECH150.50 EUR5.10%
  • CO.DON2.69 EUR4.26%

FLOP

  • 4SC0.80 EUR-8.05%
  • CYTOS0.16 CHF-5.88%
  • WILEX2.15 EUR-4.44%

TOP

  • BIOFRONTERA2.85 EUR29.5%
  • ADDEX3.30 CHF6.5%
  • BB BIOTECH150.50 EUR2.6%

FLOP

  • CYTOS0.16 CHF-33.3%
  • 4SC0.80 EUR-31.6%
  • PAION2.20 EUR-27.9%

TOP

  • SANTHERA81.90 CHF2072.4%
  • CO.DON2.69 EUR174.5%
  • PAION2.20 EUR144.4%

FLOP

  • CYTOS0.16 CHF-95.9%
  • 4SC0.80 EUR-54.8%
  • THERAMETRICS0.07 CHF-50.0%

No liability assumed, Date: 20.10.2014


Current issue

All issues

Product of the week

Products